Preliminary Results

Molins PLC 29 February 2008 29 February 2008 FOR IMMEDIATE RELEASE 2007 PRELIMINARY ANNOUNCEMENT Molins PLC, the international specialist engineering company, announces its results for the year ended 31 December 2007. 2007 2006 Sales £89.3m £88.6m Underlying operating profit* £5.4m £7.6m Profit before tax - continuing operations £7.4m £5.4m Profit/(loss) for the period £7.9m £(8.5)m Underlying earnings per share* 18.0p 24.2p Basic earnings/(loss) per share 42.0p (45.6)p Dividends per share 7.0p 4.0p Cash generated from operations before reorganisation - continuing operations £8.8m £13.5m Net debt £7.6m £12.3m * Continuing operations before net pension credit of £3.0m (2006: £1.5m) and reorganisation costs in 2006 of £2.6m. • Another year of strong operating cash flow • Profit for the period after three years of losses • Underlying operating profit of £5.4m (2006: £7.6m) • Interim dividend payment (in lieu of final) of 5p per share • Circular to shareholders posted today re Saunderton property Peter Byrom, Chairman, commented: 'Tobacco Machinery remains well placed to continue to deliver strong results, although the favourable sales mix that benefited the division in 2007 is not expected to be repeated in 2008. Performance in Packaging Machinery is expected to improve, principally through progress that we expect to see at Langen Packaging, although that business continues to face a considerable currency impact. The Scientific Services businesses entered the year with stronger momentum compared with the previous year, and, even though each of the businesses works to short order lead times, we expect to see an improved performance in the current year.' Enquiries: Molins PLC Tel: 020 7638 9571 Dick Hunter, Chief Executive; David Cowen, Group Finance Director Issued by: Citigate Dewe Rogerson Tel: 020 7638 9571 Margaret George CHAIRMAN'S STATEMENT I am pleased to report that the Group returned to profit in the year with a post-tax profit of £7.9m (2006: £8.5m loss). Underlying operating profit (continuing operations before net pension credit and reorganisation costs) was £5.4m (2006: £7.6m), on similar sales of £89.3m (2006: £88.6m). Basic earnings per share amounted to 42.0p (2006: 45.6p loss). Underlying earnings per share amounted to 18.0p (2006: 24.2p). As in the previous two years, cash flow was again strong, with £8.8m generated from continuing operations before reorganisation costs. Net debt reduced by £4.7m in the year to £7.6m. The Board has declared an interim dividend (in lieu of final) of 5p per ordinary share, making a total of 7p for the year. (2006: 4p). Property Today, the Company posted a circular to shareholders seeking approval for the grant of an option to e-shelter facility services GmbH to complete the purchase of the Saunderton property on or before 3 October 2008 for a cash consideration of £17.5m. The circular includes a notice convening a general meeting of the Company on 18 March 2008 at which the approval will be sought. If completed, the transaction will result in net cash proceeds, after costs and taxation, of approximately £15.7m, and generate a profit to the Group of approximately £3.7m. The Company sold the property in Nottingham in August 2007 for £3.7m before costs. After costs and taxation, net proceeds amounted to £3.3m and profit after taxation of £1.6m was generated. This followed the sale in 2006 of the Sandiacre Rose Forgrove business which operates from the site. Board We announced on 25 January 2008 that I would be retiring as Chairman of the Board at the end of January 2009, after what will be 10 years on the Board. We are in the process of recruiting a non-executive director with a view to the new director becoming Chairman next year. We also announced that Dick Hunter, who has been a member of the Board since 2004, had been appointed Chief Executive. Outlook Tobacco Machinery remains well placed to continue to deliver strong results, although the favourable sales mix that benefited the division in 2007 is not expected to be repeated in 2008. Performance in Packaging Machinery is expected to improve, principally through progress that we expect to see at Langen Packaging, although that business continues to face a considerable currency impact. The Scientific Services businesses entered the year with stronger momentum compared with the previous year, and, even though each of the businesses works to short order lead times, we expect to see an improved performance in the current year. Peter Byrom, Chairman, 29 February 2008 OPERATING REVIEW TOBACCO MACHINERY The Tobacco Machinery division achieved a significantly improved level of profitability in 2007, following completion of a wide-ranging restructuring programme. Sales in the year were £32.9m (2006: £36.2m) and operating profit was £3.7m (2006: £1.9m before reorganisation costs). The division comprises operations in the UK, Czech Republic, Singapore, South America and the USA, which, together with service engineers based in other countries, provides the ability to meet customers' needs efficiently in all parts of the world. The division experienced an increase in sales of after-market products, partly reflecting the favourable timing of orders towards the end of the previous year. However, this was more than offset by a reduction in lower margin sales of rebuild equipment, which had entered the year with a low order book. With the improvement in the cost base and efficiency of the business following the reorganisation carried out over the last three years, and the change in sales mix, the division produced considerably improved profitability. Market conditions continue to be challenging with a significant amount of consolidation within the cigarette manufacturing industry. Mergers and acquisitions of cigarette manufacturers continue, as well as the relocation of manufacturing activity from higher cost economies to lower cost environments. Sales opportunities for the division are driven by specific customer investment requirements. Against this backdrop, Molins Tobacco Machinery has continued to focus on maintaining excellent contact with its customer base and providing after-market services and a range of niche manufacturing equipment on an international basis. The Europe, Middle East and Africa regional sales team is based in Saunderton, UK, and services this wide geographical area through a combination of regional sales managers, service engineers and industry specific agents. In 2007 there was a low level of demand for new capital equipment within the higher cost economies in this region. However, activity with the key customers in North Africa continued to be strong and the team of locally based service engineers has been enlarged in this area in response to the market opportunities. Spare parts and service kit sales were significantly ahead of the prior year, helped by the focus on key account management programmes and work done with customers to improve the performance of their manufacturing equipment. The North American market is serviced through the division's long-established operation in Richmond, Virginia. Molins Richmond performed well in the year, with increased sales of equipment to the independent cigarette manufacturers. Molins Far East, based in Singapore, services the Asian markets. Order intake for this region was higher than in 2006, although continued consolidation within the state-controlled industry in China and development of its indigenous machinery manufacturing, resulted in a reduction in demand for both capital equipment and spare parts in China. Order intake overall benefited from a particularly large spare parts order from a key regional customer. The process of developing new products with suppliers based in the region and marketing these products through the division's sales and service organisations has continued successfully. Molins do Brasil supplies the full range of Molins' original equipment, rebuild machinery, spare parts and services to the cigarette manufacturers based within South and Central America. As a result of the division's reorganisation, Molins do Brasil is now the rebuild machinery manufacturing centre for the division and is working closely with each of the regional sales and service teams to develop sales of this equipment. The manufacturing operation in Plzen, Czech Republic, continued to grow strongly. The relocation of all machined parts that were previously manufactured at Saunderton to Plzen was successfully completed in the year, together with the majority of the machinery assembly activity. The division successfully launched a new mid-speed cigarette maker, Octave, at the Tabexpo industry trade show towards the end of the year. The Octave has been developed in partnership with a niche European supplier of tobacco processing technology and is targeted at those segments within the industry that require machinery with the highest level of product quality and the greatest level of manufacturing flexibility. The initial market response has been positive and the first machine will be installed in a customer's factory during the first half of 2008. The UK and Brazilian based engineering teams continue to focus on the development of upgrade and enhancement kits for the large Molins machine base installed in cigarette factories world-wide. In summary, the division benefited from a period of stability following completion of the restructuring programme and with lower costs and improved service, is well placed to continue its development in 2008, though a less favourable sales mix is likely to lead to a reduction in profit margins. PACKAGING MACHINERY Having entered the year with a significant order book, the division delivered higher sales of £38.7m, compared with £33.9m in the previous year. However, owing to project completion issues at Langen Packaging, profitability was weak and operating profit for the division fell to £0.3m (2006: £2.5m). ITCM, based in Coventry, UK, delivered a solid year's performance, with sales and profit at similar levels to the previous year. The business provides a unique combination of bespoke creative engineering solutions for customers' complex production and packaging needs, together with the production of the machinery that delivers the solution, either as a one-off machine or in production volumes. Following the success of the increased focus on business development over the last few years, further resource has been applied to this area. The customer base continues to expand, with a number of orders being received from the pharmaceutical sector, as well as the food and personal care sectors. The highlight in the year was the receipt of a significant order from an important pharmaceutical customer, which will be delivered progressively through 2008. One of the features of the business is that it tends to receive a relatively small number of high-value contracts in the year, and it is important to maintain a good level of order prospects, as such projects often take a considerable time to convert to an order. As previously indicated, the business was becoming space constrained and during the year an extension was built which has increased the workshop space by 50%. The business also invested in its managerial and technical capabilities in the year and in a new enterprise resource planning system. Langenpac, based in Wijchen, the Netherlands, supplies highly automated product handling, cartoning and end-of-line machinery to European customers and progressively to customers in Asia. It entered the year with a strong order book, which led to the highest level of sales in its 20 year history. Projects delivered in the year included the supply of a high-value integrated packing line to a blue-chip cereal manufacturer, which reinforced Langenpac's capabilities to manage such large-scale projects. Following product development over the last few years, it increased its sales of more standard cartoning machines, some of which were sold by Langen Packaging into North America. However, whilst sales levels were strong, order intake in the year was much reduced from the particularly high levels experienced in the previous year. The business continues to focus on specific market niches and segments, including contact lenses, premium packaging for the drinks industry, tissues and stick-packs, as well as on its more traditional food sectors. Despite record sales and profits, the business returned a lower than planned margin resulting from a combination of low margins on the bought-in elements of its integrated packing lines, pricing pressures and operational inefficiencies. The expected move into new leased premises did not take place in the year but is expected to occur in the second half of 2008 and this should help the business improve its project delivery efficiency. Langen Packaging, based in Mississauga, Canada, had a difficult year and incurred a considerable loss. Having started the year with a strong order book, profit margins on a number of its integration and robotic projects were much lower than planned as the business experienced cost over-runs. With the majority of Langen's customers being based in the US, the competitive position of the business was also affected by the 15% strengthening over the year of the Canadian dollar against the US dollar. A number of actions have been taken, including a change in senior management and a wide-ranging improvement plan has been instigated. Market conditions are challenging, with signs of an economic slow-down in the US, but the business entered the year with a satisfactory order book and this, together with operational improvements, is expected to lead to an improved performance in 2008. Cerulean Packing, which supplies tube packing machinery from its base in Milton Keynes, UK, experienced much lower sales and profit levels compared with the previous year. Prospects, though, for this range of equipment are now more encouraging with the possibility of an improvement in activity levels in the year. Overall, the financial performance of the division was disappointing, owing mostly to the underperformance at Langen Packaging. The causes of this underperformance are understood but will take some time to rectify. Good progress was made at ITCM and Langenpac, and although market conditions are challenging, we are optimistic that they will continue to progress in the current year. SCIENTIFIC SERVICES The Scientific Services division, which comprises Cerulean and Arista Laboratories, entered the year with a relatively low order book which, as expected, led to reduced sales and profit compared with 2006. Sales in the year were £17.7m (2006: £18.5m) and operating profit reduced to £1.4m (2006: £3.2m). Cerulean, based in Milton Keynes, UK, is the market-leading supplier of quality control instruments and analytical smoke constituent capture machinery to the tobacco industry, independent laboratories and government bodies. The business has a considerable network of global sales and service offices, which provide localised support to its extensive customer base. Overall, the business experienced a small increase in sales compared with the previous year, with the impact of the sale of a large project for a closed-loop control system outweighing a reduction in sales across the balance of Cerulean's product range. Profits, though, were lower, reflecting the reduced margin on this large project compared with margins achieved on its standard product range. As previously advised, the business experienced a significant reduction in demand in the second half of 2006. This led to a much reduced order book as it entered the year and this demand pattern continued into the first half of 2007. However, a strong increase in order intake in the second half of the year has continued into the first few weeks of 2008. Overall, order intake for instruments showed growth over the previous year, for both the established QTM range as well as the newer C(2) range which, after a process of validation and customer trials, is finding its place in resolving customers' needs. But with the consolidation within the tobacco sector impacting demand for new instrumentation and quality control systems, expectations remain quite fragile. Product development activities continue to be a key part of Cerulean's strategic development. The business now offers to the market its broadest product portfolio, having launched a number of small manual measurement instruments during the year, as well as introducing the Quantum range of instruments. These instruments use established technology in a more accessible format, adding improvements in speed and connectivity capability. Arista Laboratories, based in Richmond, Virginia and Kingston upon Thames, UK, is an independent tobacco and cigarette smoke constituent testing laboratory, for regulatory, research and product development purposes. The business experienced a disappointing year in terms of its financial performance. Whilst it performed at similar levels in the first half of the year compared with the comparable period last year, second half performance, as previously anticipated, was significantly impacted by the delay in order placement by its main UK customer. This led to significantly reduced sales from the UK operation compared with 2006. The market drivers for the business, though, remain positive. Regulation in respect of tobacco products continues to grow in many parts of the world including the UK, the EU, North and South America. Arista has developed its range of testing capabilities to meet these demands, and in particular has invested in its ignition propensity testing laboratory in the UK. FINANCIAL REVIEW The Group returned to profit in the year and generated strong cash flow. Profit for the period was £7.9m (2006: £8.5m loss), which benefited from profit in respect of discontinued operations of £2.3m (2006: £12.2m loss). Underlying operating profit (continuing operations before net pension credit and reorganisation costs) was lower than the previous year at £5.4m (2006: £7.6m). Underlying earnings per share decreased to 18.0p (2006: 24.2p) and basic earnings per share amounted to 42.0p (2006: 45.6p loss). The Group maintained strong cash flows, generating £8.8m from continuing operations before reorganisation costs, with net debt reducing by £4.7m in the year. Operating results The trading performance of the Group is discussed in the Operating review. Group revenue was £89.3m for continuing businesses, compared with £88.6m in 2006. Tobacco Machinery division sales reduced to £32.9m (2006: £36.2m) but operating profit increased to £3.7m (2006: £1.9m before reorganisation costs of £2.6m). Packaging Machinery division sales increased to £38.7m (2006: £33.9m), but the division's operating profit decreased to £0.3m (2006: £2.5m). Scientific Services division sales decreased to £17.7m (2006: £18.5m) and operating profit decreased to £1.4m (2006: £3.2m). Interest and taxation Net interest expense in 2007 was £1.0m (2006: £1.1m). The taxation charge for continuing operations was £1.8m (2006: £1.7m after reorganisation costs), resulting in an effective tax rate of 24% (2006: 31%), reflecting the reduction in the UK corporation tax rate to 28% on the Group's deferred tax balances and a number of non-recurring credits. Discontinued businesses Profit from discontinued operations was £2.3m in the year, which comprised £1.6m profit from the sale of a property in Nottingham, which had been retained by the Group when the Sandiacre Rose Forgrove business was sold in 2006, and the release of warranty and disposal provisions of £0.7m relating to the 2006 sales of Sasib S.p.A. and Sandiacre Rose Forgrove. Earnings per share Basic earnings per share amounted to 42.0p (2006: 45.6p loss). Basic earnings per share for continuing operations amounted to 29.7p (2006: 20.2p) and underlying earnings per share (continuing operations before net pension credit and reorganisation costs) amounted to 18.0p (2006: 24.2p). Dividends The Board has decided to pay an interim dividend (in lieu of final) of 5p per ordinary share which, together with the interim dividend of 2p paid in October 2007, results in a total dividend of 7p per ordinary share in respect of 2007 (2006: 4p per ordinary share). The dividend will be paid on 4 April 2008 to shareholders on the register on 14 March 2008. Cash, treasury and funding activities Group net debt reduced to £7.6m at the year end (2006: £12.3m). Net cash inflow from continuing operations before reorganisation costs, was £8.8m (2006: £13.5m). Reorganisation costs of £1.3m (2006: £1.4m) relating to the Tobacco Machinery division were paid in the year, having been charged in the income statement in 2006. A payment of £0.5m was made in the year to the UK defined benefit pension scheme, consequent to the disposal of the Nottingham property. Net taxation payments of £0.7m (2006: £1.0m) and net interest payments of £1.0m (2006: £1.1m) were also made in the year. Investment expenditure in property, plant and equipment was £2.5m (2006: £1.4m) and product development expenditure was £1.2m (2006: £1.9m). In addition to the sale of the Nottingham property, the Group sold property, plant and equipment assets in the year which yielded cash receipts of £0.1m (2006: £1.3m). The net cash inflow in respect of the discontinued businesses was £4.2m (2006: £2.7m outflow), comprising net receipts of £0.9m from Paritel S.p.A., the acquirer of the Sasib business, following the settlement of all outstanding claims between the parties in respect of the sale of that business, £3.7m proceeds from the sale of the Nottingham property, less £0.4m outflow in respect of the Sandiacre Rose Forgrove and Sasib businesses. There were no significant changes during the year in the financial risks, principally currency risks and interest rate movements, to which the business is exposed and the Group treasury policy has remained unchanged. The Group does not trade in financial instruments and enters into derivatives (principally forward foreign exchange contracts) solely for the purpose of minimising currency exposures on sales or purchases in other than the functional currencies of its various operations. The Group maintains bank facilities appropriate to its expected needs. In the UK, at 31 December 2007, these comprised secured, committed borrowing facilities of £16.1m (2006: £23.1m), which had reduced in line with the scheduled loan repayments under those pre-existing facilities. In December 2007 new committed bilateral borrowing facilities were entered into with Lloyds TSB Bank plc and Fortis Bank NA/SV totalling £18m. These new facilities are committed for five years, expiring in December 2012. The facilities, which are subject to covenants covering earnings, interest cover and tangible net worth, are both sterling and multi-currency denominated. Additionally, the Group maintains committed facilities from overseas banks of £5.2m, denominated in US dollars and euros. Short-term overdrafts and borrowings are utilised around the Group to meet local cash requirements. These are typically denominated in local currencies. Foreign currency borrowings are used to hedge investments in overseas subsidiaries where appropriate. Pension valuations The Group's main defined benefit scheme is in the UK. Changes were made to the benefit structure of this scheme in 2006, principally moving the pension accrual link from final salary to career average for future entitlements, thereby reducing the uncertainty of the cost to the fund in respect of the benefit. Also, employee contribution rates were increased to 8% of earnings from 1 July 2007 for most employees, but to 6% for those employees joining the scheme after 1 April 2006 for which a lower benefit rate is accrued. A scheme specific funding valuation as at 30 June 2006 was completed by the fund's trustee during the year. This showed a funding level of 102% of liabilities, which was a similar position to the previous formal valuation in 2003 despite an increase in the scheme's liabilities of 6% due to changed mortality assumptions applicable at the date of the valuation. At the same time the trustee is obliged to look at the solvency position of the fund and this showed a deficit of 31%. Valuations are extremely sensitive to a number of factors outside the control of the Group, including discount rates. Company contributions for ongoing benefits have been agreed at 5% in respect of members who joined the scheme after 1 April 2006 and 11% for all other members. During the year the Company made payments to the fund of £1.2m for the regular cost of benefits, £0.7m for pension augmentation costs relating to redundancies announced in 2006 (and in respect of which a further and final payment of £0.6m will be made before 30 June 2008), and £0.5m additional funding consequent to the sale by the Group of the Nottingham property. The Group has adopted IAS 19 (revised) Employee benefits as its basis of accounting for pension costs. The 2007 valuation of the UK fund's assets and liabilities was undertaken as at 31 December 2007 based on detailed valuation work carried out as at 30 June 2006, updated to reflect changes existing at the 2007 year end. The significantly smaller US defined benefit schemes were valued at 31 December 2007, using actuarial data as of 1 January 2007, updated for conditions existing at the year end. Under IAS 19 (revised) the Group has elected to recognise all actuarial gains and losses outside of the income statement. In 2007, the net pension credit arising from the Group's defined benefit schemes for continuing operations was £3.0m (2006: £1.5m), before accounting for deferred tax. The IAS 19 (revised) valuation of the UK fund showed a net surplus of £25.9m at 31 December 2007 (2006: £6.6m deficit) and the US pension funds showed an aggregated net surplus of £0.4m (2006: £0.4m deficit), all amounts being before tax. The combined market value of the Group's defined benefit schemes' assets at 31 December 2007 was £367.7m, and the value of the liabilities on an IAS 19 (revised) basis at 31 December 2007 was £341.4m. Property A circular was sent to shareholders on 29 February 2008, containing details of a proposed transaction in respect of surplus property owned by the Company in Saunderton, UK. In summary, approval is being sought to grant the prospective purchaser of the site an option to acquire the property on or before 3 October 2008 for a cash consideration of £17.5m. The book value of the property subject to the transaction was £13.2m at 31 December 2007 before deferred tax, £12.6m net of deferred tax. If completed the transaction will result in net cash proceeds, after costs and taxation of approximately £15.7m and generate a profit to the Group of approximately £3.7m. Full details of the proposed transaction are contained in the circular. Equity Group equity at 31 December 2007 was £52.3m (2006: £24.1m), representing 259p per ordinary share. The increase arises from actuarial gains in respect of the Group's defined benefit schemes of £18.0m, profit for the period of £7.9m, currency translation movements on the net assets of the overseas businesses of £1.3m, deferred tax adjustments to items previously taken directly to equity of £1.8m and equity-settled share-based transactions of £0.3m, net of dividend payments of £1.1m. Consolidated income statement 2007 2006 Before reorg. Reorg. Total costs costs Total Notes £m £m £m £m (note 3) Continuing operations Revenue 2 89.3 88.6 - 88.6 Cost of sales (63.2) (58.1) (1.5) (59.6) Gross profit 26.1 30.5 (1.5) 29.0 Other operating income 0.2 0.5 - 0.5 Distribution expenses (5.4) (7.7) (0.1) (7.8) Administrative expenses (12.3) (13.9) (0.1) (14.0) Other operating expenses (0.2) (0.3) (0.9) (1.2) Operating profit 2, 4 8.4 9.1 (2.6) 6.5 Financial income 0.2 0.2 - 0.2 Financial expenses (1.2) (1.3) - (1.3) Net financing costs (1.0) (1.1) - (1.1) Profit before tax 7.4 8.0 (2.6) 5.4 Taxation (1.8) (2.4) 0.7 (1.7) Profit from continuing operations 5.6 5.6 (1.9) 3.7 Discontinued operations Profit/(loss) from discontinued operations 9 2.3 (12.2) - (12.2) Profit/(loss) for the period 7.9 (6.6) (1.9) (8.5) Basic earnings/(loss) per ordinary share 5 42.0p (45.6)p Diluted earnings/(loss) per ordinary share 38.0p (45.6)p Continuing operations Basic earnings per ordinary share 5 29.7p 20.2p Diluted earnings per ordinary share 27.0p 18.4p Consolidated balance sheet 2007 2006 Notes £m £m Non-current assets Intangible assets 13.3 13.3 Property, plant and equipment 23.4 22.3 Other receivables 0.5 0.5 Employee benefits 6 17.2 - Deferred tax assets 0.4 2.7 54.8 38.8 Current assets Inventories 15.1 12.9 Trade and other receivables 18.3 23.4 Current tax assets 0.3 0.5 Cash and cash equivalents 3.5 4.7 Assets held for sale 9 - 1.8 37.2 43.3 Current liabilities Bank overdrafts (0.8) (0.1) Interest-bearing loans and borrowings (0.6) (4.3) Trade and other payables (25.1) (26.8) Current tax liabilities (1.0) (0.8) Provisions (1.8) (2.8) (29.3) (34.8) Net current assets 7.9 8.5 Total assets less current liabilities 62.7 47.3 Non-current liabilities Interest-bearing loans and borrowings (9.7) (12.6) Trade and other payables - (0.2) Employee benefits 6 - (7.0) Deferred tax liabilities (0.7) (3.4) (10.4) (23.2) Net assets 2 52.3 24.1 Equity Issued capital 5.0 5.0 Share premium 26.0 26.0 Reserves 5.0 3.7 Retained earnings 16.3 (10.6) Total equity 52.3 24.1 Consolidated statement of cash flows 2007 2006 Note £m £m Continuing operations Operating activities Operating profit 8.4 6.5 Reorganisation costs included in operating profit - 2.6 Amortisation 1.2 1.1 Depreciation 2.0 2.2 Profit on sale of property, plant and equipment - (0.3) Other non-cash items (2.7) (1.5) Pension payments (1.2) (0.7) Working capital movements: - (Increase)/decrease in inventories (1.4) 2.9 - Decrease/(increase) in trade and other receivables 5.4 (6.5) - (Decrease)/increase in trade and other payables (2.8) 7.7 - Decrease in provisions (0.1) (0.5) Cash generated from operations before reorganisation 8.8 13.5 Reorganisation costs paid (1.3) (1.4) Pension payment following sale of Nottingham property (0.5) - Cash generated from operations 7.0 12.1 Taxation paid (0.7) (1.0) Net cash from operating activities 6.3 11.1 Investing activities Proceeds from sale of property, plant and equipment 0.1 1.3 Acquisition of property, plant and equipment (2.5) (1.4) Development expenditure (1.2) (1.9) Net cash from investing activities (3.6) (2.0) Financing activities Interest received 0.2 0.2 Interest paid (1.2) (1.3) Decrease in borrowings (7.0) (1.5) Dividends paid (1.1) - Net cash from financing activities (9.1) (2.6) Discontinued operations Net cash from operating activities - (0.2) Net cash from investing activities 4.2 (2.2) Net cash from financing activities - (0.3) Net cash from discontinued operations 4.2 (2.7) Net (decrease)/increase in cash and cash equivalents 7 (2.2) 3.8 Cash and cash equivalents at 1 January 4.6 0.9 Effect of exchange rate fluctuations on cash held 0.3 (0.1) Cash and cash equivalents at period end 2.7 4.6 Consolidated statement of recognised income and expense 2007 2006 Note £m £m Currency translation movements arising on foreign currency net investments 1.3 (1.3) Actuarial gains 27.1 3.8 Withholding tax on pension asset 6 (9.1) - Tax on items taken directly to equity 1.8 - Net income recognised directly in equity 21.1 2.5 Currency translation movements transferred to loss on disposals Profit/(loss) for the period - 0.2 7.9 (8.5) Total recognised income and expense for the period 29.0 (5.8) Notes to preliminary announcement 1. The Group's accounts have been prepared in accordance with International Accounting Standards and International Financial Reporting Standards that were effective at 31 December 2007 and adopted by the EU. The financial information set out above does not constitute the Company's statutory accounts for the years ended 31 December 2007 or 2006. Statutory accounts for 2006 have been delivered to the registrar of companies, and those for 2007 will be delivered following the Company's Annual General Meeting. The auditors have reported on those accounts; their reports were (i) unqualified, (ii) did not include references to any matters to which the auditors drew attention by way of emphasis without qualifying their reports and (iii) did not contain statements under section 237 (2) or (3) of the Companies Act 1985. 2. Segmental analysis Business segments Tobacco Packaging Scientific Machinery Machinery Services Total 2007 2006 2007 2006 2007 2006 2007 2006 £m £m £m £m £m £m £m £m Revenue -continuing operations 32.9 36.2 38.7 33.9 17.7 18.5 89.3 88.6 -discontinued operations - 12.8 Revenue - total 89.3 101.4 Underlying segment operating profit before net pension credit and reorganisation costs 3.7 1.9 0.3 2.5 1.4 3.2 5.4 7.6 Reorganisation costs - (2.6) - - - - - (2.6) Segment operating profit/(loss) before net pension credit 3.7 (0.7) 0.3 2.5 1.4 3.2 5.4 5.0 Net pension credit (ex. curtailment costs) 3.0 1.5 Operating profit 8.4 6.5 Net financing costs (1.0) (1.1) Profit before tax 7.4 5.4 Taxation (1.8) (1.7) Profit from continuing operations 5.6 3.7 Discontinued operations Profit/(loss) from discontinued operations 2.3 (12.2) Profit/(loss) for the period 7.9 (8.5) Segment net assets 24.2 24.5 3.5 2.7 16.8 15.9 44.5 43.1 Net (liabilities)/assets - discontinued operations (0.8) 1.3 Unallocated net assets/(liabilities) 8.6 (20.3) (including net debt and pension assets/liabilities) Total net assets 52.3 24.1 Geographical segments Revenue Segment net assets (by destination of goods) (by location of assets) 2007 2007 2006 2006 2007 2006 £m % £m % £m £m Continuing operations United Kingdom 13.0 15 9.2 11 27.4 27.9 Continental Europe 12.9 14 18.1 20 10.0 6.4 North America 29.3 33 23.9 27 5.9 7.2 Asia 18.3 20 22.0 25 0.2 0.6 Rest of the world 15.8 18 15.4 17 1.0 1.0 89.3 100 88.6 100 44.5 43.1 3. The reorganisation costs in 2006 of £2.6m before tax relate to the restructuring of the Tobacco Machinery division. 4. The Group accounts for pensions under IAS 19 (revised) Employee benefits. An actuarial valuation of the UK pension fund at 30 June 2006 was completed in the year and the assumptions of this valuation have been applied in the financial statements, updated to reflect conditions at 31 December 2007. Operating profit includes a net pension credit of £3.0m (2006: £1.5m) in respect of ongoing benefits comprising current service costs of £1.8m, interest on the pension obligations of £18.4m, offset by the expected return on the schemes' assets of £23.2m. In addition in 2006 there were curtailment costs of £0.9m arising from redundancies, which are reported in reorganisation costs, and in respect of Sandiacre Rose Forgrove, a discontinued operation, £0.3m of pension costs less £0.8m of curtailment benefits. 5. Basic earnings/(loss) per ordinary share is based upon the profit for the period of £7.9m (2006: £8.5m loss) and on a weighted average of 18,903,387 shares in issue during the year (2006: 18,576,888). Basic earnings per ordinary share on continuing operations is based upon the profit for the period of £5.6m (2006: £3.7m) and the weighted average number of ordinary shares as shown above. Underlying earnings per ordinary share, which is calculated on continuing operations before net pension credit and reorganisation costs, was 18.0p for the year (2006: 24.2p). 6. Employee benefits include the aggregated net pension surpluses of the UK defined benefit pension scheme of £25.9m (31 December 2006: £6.6m deficit) and the US defined pension schemes of £0.4m (31 December 2006: £0.4m deficit), all figures before tax. The Group has assessed the impact of the IAS 19 (revised) asset ceiling and has considered the principles set out in IFRIC14 IAS19 - The limit on a defined benefit asset, minimum funding requirement and their interaction in determining the inclusion of the full value of the pension asset on the balance sheet at 31 December 2007. The carrying value of the surplus in the UK scheme has been shown net of withholding tax reflecting the expected manner of its recovery at the end of the life of the scheme. 7. Reconciliation of net cash flow to movement in net debt 2007 2006 £m £m Net (decrease)/increase in cash and cash equivalents (2.2) 3.8 Cash inflow from movement in borrowings and finance leases 7.0 1.8 Change in net debt resulting from cash flows 4.8 5.6 Decrease in borrowings and finance leases on sale of discontinued operations - 0.9 Translation movements (0.1) 0.2 Movement in net debt in the period 4.7 6.7 Opening net debt (12.3) (19.0) Closing net debt (7.6) (12.3) 8. Analysis of net debt 2007 2006 £m £m Cash and cash equivalents - current assets 3.5 4.7 Bank overdrafts - current liabilities (0.8) (0.1) Interest-bearing loans and borrowings - current liabilities (0.6) (4.3) Interest-bearing loans and borrowings - non-current (9.7) (12.6) liabilities (7.6) (12.3) Closing net debt 9. Discontinued operations and assets held for sale On 30 August 2007, the Group sold its freehold interest in a property in Nottingham that had been classified as an asset held for sale at 31 December 2006 and had been retained by the Group when it sold the Sandiacre Rose Forgrove business in 2006. The cash consideration was £3.7m and the profit on sale before and after tax was £1.5m. Also the Group earned rental income of £0.1m from the property to the date of its sale. In addition £0.7m profit in 2007 arises from the negotiated settlement of claims and the release of provisions in connection with the prior year disposals of Sandiacre Rose Forgrove and Sasib S.p.A. These businesses were sold on 18 December 2006 and 28 July 2006 respectively, and resulted in a loss from discontinued operations of £12.2m in 2006. 10. Subsequent event On 29 February 2008 the Company posted a circular to shareholders seeking approval for the grant of an option to e-shelter facility services GmbH to complete the purchase for a cash consideration of £17.5m of the Saunderton property on or before 3 October 2008. The circular includes a notice convening a general meeting of the Company on 18 March 2008 at which the approval will be sought. If completed the transaction will result in net cash proceeds, after costs and taxation, of approximately £15.7m, and will generate a profit to the Group of approximately £3.7m. The property is included as property, plant and equipment in the balance sheet, with a carrying value of £13.2m (before deferred tax) at 31 December 2007. 11. The Annual Report and Accounts will be sent to all shareholders in March 2008 and additional copies will be available from the Company's registered office at 11 Tanners Drive, Blakelands, Milton Keynes, MK14 5LU. This information is provided by RNS The company news service from the London Stock Exchange

Companies

MPAC Group (MPAC)
UK 100

Latest directors dealings